Literature DB >> 20563840

ROCK: a breast cancer functional genomics resource.

David Sims1, Borisas Bursteinas, Qiong Gao, Ekta Jain, Alan MacKay, Costas Mitsopoulos, Marketa Zvelebil.   

Abstract

The clinical and pathological heterogeneity of breast cancer has instigated efforts to stratify breast cancer sub-types according to molecular profiles. These profiling efforts are now being augmented by large-scale functional screening of breast tumour cell lines, using approaches such as RNA interference. We have developed ROCK ( rock.icr.ac.uk ) to provide a unique, publicly accessible resource for the integration of breast cancer functional and molecular profiling datasets. ROCK provides a simple online interface for the navigation and cross-correlation of gene expression, aCGH and RNAi screen data. It enables the interrogation of gene lists in the context of statistically analysed functional genomic datasets, interaction networks, pathways, GO terms, mutations and drug targets. The interface also provides interactive visualisations of datasets and interaction networks. ROCK collates data from a wealth of breast cancer molecular profiling and functional screening studies into a single portal, where analysed and annotated results can be accessed at the level of a gene, sample or study. We believe that portals such as ROCK will not only afford researchers rapid access to profiling data, but also aid the integration of different data types, thus enhancing the discovery of novel targets and biomarkers for breast cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20563840     DOI: 10.1007/s10549-010-0945-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  17 in total

1.  Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma.

Authors:  L Melchor; A Brioli; C P Wardell; A Murison; N E Potter; M F Kaiser; R A Fryer; D C Johnson; D B Begum; S Hulkki Wilson; G Vijayaraghavan; I Titley; M Cavo; F E Davies; B A Walker; G J Morgan
Journal:  Leukemia       Date:  2014-01-13       Impact factor: 11.528

Review 2.  Combinatorial drug therapy for cancer in the post-genomic era.

Authors:  Bissan Al-Lazikani; Udai Banerji; Paul Workman
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908

3.  Genomic distance entrained clustering and regression modelling highlights interacting genomic regions contributing to proliferation in breast cancer.

Authors:  Tim J Dexter; David Sims; Costas Mitsopoulos; Alan Mackay; Anita Grigoriadis; Amar S Ahmad; Marketa Zvelebil
Journal:  BMC Syst Biol       Date:  2010-09-08

4.  Functional viability profiles of breast cancer.

Authors:  Rachel Brough; Jessica R Frankum; David Sims; Alan Mackay; Ana M Mendes-Pereira; Ilirjana Bajrami; Sara Costa-Cabral; Rumana Rafiq; Amar S Ahmad; Maria Antonietta Cerone; Rachael Natrajan; Rachel Sharpe; Kai-Keen Shiu; Daniel Wetterskog; Konstantine J Dedes; Maryou B Lambros; Teeara Rawjee; Spiros Linardopoulos; Jorge S Reis-Filho; Nicholas C Turner; Christopher J Lord; Alan Ashworth
Journal:  Cancer Discov       Date:  2011-08-02       Impact factor: 39.397

5.  GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors.

Authors:  Andrea Morandi; Lesley-Ann Martin; Qiong Gao; Sunil Pancholi; Alan Mackay; David Robertson; Marketa Zvelebil; Mitch Dowsett; Ivan Plaza-Menacho; Clare M Isacke
Journal:  Cancer Res       Date:  2013-05-06       Impact factor: 12.701

6.  EFNA3 long noncoding RNAs induced by hypoxia promote metastatic dissemination.

Authors:  L Gómez-Maldonado; M Tiana; O Roche; A Prado-Cabrero; L Jensen; A Fernandez-Barral; I Guijarro-Muñoz; E Favaro; G Moreno-Bueno; L Sanz; J Aragones; A Harris; O Volpert; B Jimenez; L del Peso
Journal:  Oncogene       Date:  2014-07-14       Impact factor: 9.867

7.  The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines.

Authors:  Andrea Morandi; Valentina Barbetti; Maria Riverso; Persio Dello Sbarba; Elisabetta Rovida
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

Review 8.  Neuregulin 3 and erbb signalling networks in embryonic mammary gland development.

Authors:  Naoko Kogata; Marketa Zvelebil; Beatrice A Howard
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-05-07       Impact factor: 2.673

9.  Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment.

Authors:  Sílvia Cufí; Alejandro Vazquez-Martin; Cristina Oliveras-Ferraros; Bruna Corominas-Faja; Ander Urruticoechea; Begoña Martin-Castillo; Javier A Menendez
Journal:  Oncotarget       Date:  2012-12

10.  Embryonic mammary signature subsets are activated in Brca1-/- and basal-like breast cancers.

Authors:  Marketa Zvelebil; Erik Oliemuller; Qiong Gao; Olivia Wansbury; Alan Mackay; Howard Kendrick; Matthew J Smalley; Jorge S Reis-Filho; Beatrice A Howard
Journal:  Breast Cancer Res       Date:  2013-03-18       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.